{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:33:57Z","timestamp":1793136837135,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jclinepi.2026.112534","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:21:27Z","timestamp":1790205687000},"page":"112534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Capacity-related exclusions in clinical trial protocols are common, with limited assessment and almost no planning for capacity loss"],"prefix":"10.1016","volume":"200","author":[{"given":"Maeve","family":"McGovern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-9059","authenticated-orcid":false,"given":"Amy M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-8321","authenticated-orcid":false,"given":"Frances","family":"Shiely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s13063-019-3603-1","article-title":"Protection by exclusion? The (lack of) inclusion of adults who lack capacity to consent to research in clinical trials in the UK","volume":"20","author":"Shepherd","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.jclinepi.2026.112534_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpsychires.2015.08.005","article-title":"The exclusion of people with psychiatric disorders from medical research","volume":"70","author":"Humphreys","year":"2015","journal-title":"J Psychiatr Res"},{"issue":"9","key":"10.1016\/j.jclinepi.2026.112534_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/jir.12091","article-title":"Where are persons with intellectual disabilities in medical research? A survey of published clinical trials","volume":"58","author":"Feldman","year":"2014","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112534_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1532-5415.2011.03847.x","article-title":"The disappearing subject: exclusion of people with cognitive impairment and dementia from geriatrics research","volume":"60","author":"Taylor","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jclinepi.2026.112534_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jclinepi.2022.03.011","article-title":"Underserved groups remain underserved as eligibility criteria routinely exclude them from breast cancer trials","volume":"147","author":"Moloney","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112534_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jclinepi.2023.08.008","article-title":"Underrecording and underreporting of participant ethnicity in clinical trials is persistent and is a threat to inclusivity and generalizability","volume":"162","author":"Wallace","year":"2023","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12910-016-0138-9","article-title":"Research involving adults lacking capacity to consent: the impact of research regulation on \u2018evidence biased\u2019medicine","volume":"17","author":"Shepherd","year":"2016","journal-title":"BMC Med Ethics"},{"issue":"10223","key":"10.1016\/j.jclinepi.2026.112534_bib12","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/S0140-6736(20)30051-9","article-title":"Exclusion criterion: learning disability","volume":"395","author":"Spaul","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2026.112534_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ije\/dyu038","article-title":"The global prevalence of common mental disorders: a systematic review and meta-analysis 1980\u20132013","volume":"43","author":"Steel","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112534_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s40474-016-0085-7","article-title":"Systematic review of the prevalence and incidence of intellectual disabilities: current trends and issues","volume":"3","author":"McKenzie","year":"2016","journal-title":"Curr Develop Disord Rep"},{"issue":"4\u20136","key":"10.1016\/j.jclinepi.2026.112534_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000499763","article-title":"Prevalence and incidence of mild cognitive impairment across subtypes, age, and sex","volume":"47","author":"Overton","year":"2019","journal-title":"Demen Geriatr Cogn Disord"},{"key":"10.1016\/j.jclinepi.2026.112534_bib17","doi-asserted-by":"crossref","DOI":"10.3310\/nihropenres.13524.1","article-title":"Effective interventions to increase representation of under-served groups in randomised trials in UK and Ireland: a scoping literature review","volume":"4","author":"Biggs","year":"2024","journal-title":"NIHR Open Res"},{"key":"10.1016\/j.jclinepi.2026.112534_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijantimicag.2013.07.016","article-title":"Patients enrolled in randomised clinical trials are not representative of critically ill patients in clinical practice: observational study focus on tigecycline","volume":"42","author":"Zimmermann","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.jclinepi.2026.112534_bib20","series-title":"Learning from lives and deaths-people with a learning disability and autistic people (LeDeR) report for 2022","author":"White","year":"2023"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112534_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198261","article-title":"Under representation of people with epilepsy and intellectual disability in research","volume":"13","author":"Shankar","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jclinepi.2026.112534_bib22","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1111\/jocn.12215","article-title":"Assessing patient capacity to consent to treatment: an integrative review of instruments and tools","volume":"22","author":"Lamont","year":"2013","journal-title":"J Clin Nurs"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112534_bib23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3233\/JAD-180311","article-title":"Medical and research consent decision-making capacity in patients with Alzheimer\u2019s disease: a systematic review","volume":"65","author":"van Duinkerken","year":"2018","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"8","key":"10.1016\/j.jclinepi.2026.112534_bib24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1176\/ajp.2006.163.8.1323","article-title":"Assessing decisional capacity for clinical research or treatment: a review of instruments","volume":"163","author":"Dunn","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jclinepi.2026.112534_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0968533219867365","article-title":"Lost voices in research: exposing the gaps in the Mental Capacity Act 2005","volume":"19","author":"Heywood","year":"2019","journal-title":"Med L Int"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13063-023-07159-6","article-title":"Complex and alternate consent pathways in clinical trials: methodological and ethical challenges encountered by underserved groups and a call to action","volume":"24","author":"Russell","year":"2023","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112534_bib27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1192\/bjp.bp.112.121160","article-title":"Changes in capacity to consent over time in patients involved in psychiatric research","volume":"202","author":"Palmer","year":"2013","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s13063-023-07775-2","article-title":"How do trial teams plan for retention during the design stage of the trial? A scoping review","volume":"24","author":"Murphy","year":"2023","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.jclinepi.2026.112534_bib29","first-page":"467","article-title":"Chapter 11: scoping reviews","volume":"169","author":"Peters","year":"2020","journal-title":"JBI Man Evid Synth"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13063-024-07944-x","article-title":"Improving the inclusion of an under-served group in trials: development and implementation of the INCLUDE Impaired Capacity to Consent Framework","volume":"25","author":"Shepherd","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.jclinepi.2026.112534_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jclinepi.2022.10.014","article-title":"Recording and reporting of recruitment strategies in trial protocols, registries, and publications was nonexistent","volume":"152","author":"Greene","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13063-024-08194-7","article-title":"Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols","volume":"25","author":"Murphy","year":"2024","journal-title":"Trials"},{"issue":"724","key":"10.1016\/j.jclinepi.2026.112534_bib34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3399\/bjgp22X720953","article-title":"Breaking the cycle of inequalities for people with a learning disability","volume":"72","author":"Russell","year":"2022","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jclinepi.2026.112534_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/medethics-2017-104722","article-title":"Healthcare professionals\u2019 understanding of the legislation governing research involving adults lacking mental capacity in England and Wales: a national survey","volume":"44","author":"Shepherd","year":"2018","journal-title":"J Med Ethics"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112534_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/1471301211403970","article-title":"\u2018Early days\u2019: knowledge and use of the Mental Capacity Act 2005 by care home managers and staff","volume":"10","author":"Manthorpe","year":"2011","journal-title":"Dementia"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijlp.2012.11.009","article-title":"Homeward bound or bound for a home? Assessing the capacity of dementia patients to make decisions about hospital discharge: comparing practice with legal standards","volume":"36","author":"Emmett","year":"2013","journal-title":"Int J L Psychiatry"},{"key":"10.1016\/j.jclinepi.2026.112534_bib38","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2147\/CIA.S141905","article-title":"Assessing capacity to consent for research in cognitively impaired older patients","volume":"12","author":"Gilbert","year":"2017","journal-title":"Clin Inter Aging"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12910-026-01481-9","article-title":"Ethical challenges of capacity assessment in neurodevelopmental and intellectual disabilities","volume":"27","author":"Santoro","year":"2026","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.jclinepi.2026.112534_bib40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ageing\/afy108","article-title":"Approaches to capacity evaluation","volume":"47","author":"Darzins","year":"2018","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12916-020-01654-2","article-title":"Processes of consent in research for adults with impaired mental capacity nearing the end of life: systematic review and transparent expert consultation (MORECare_Capacity statement)","volume":"18","author":"Evans","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.jclinepi.2026.112534_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.111715","article-title":"Lack of data collection in clinical trials prevents us from evaluating inclusion of people with disabilities","volume":"181","author":"Cunningham","year":"2025","journal-title":"J Clin Epidemiol"},{"issue":"10491","key":"10.1016\/j.jclinepi.2026.112534_bib43","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(25)00770-6","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"405","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"10489","key":"10.1016\/j.jclinepi.2026.112534_bib44","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0140-6736(25)00672-5","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"405","author":"Hopewell","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2026.112534_bib45","series-title":"Assisted Decision-Making (Capacity) Act 2015","year":"2015"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-021-05276-8","article-title":"Developing the INCLUDE Ethnicity Framework\u2014A tool to help trialists design trials that better reflect the communities they serve","volume":"22","author":"Treweek","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.jclinepi.2026.112534_bib47","series-title":"The INCLUDE Socioeconomic Disadvantage Framework","author":"Gardner","year":"2022"},{"key":"10.1016\/j.jclinepi.2026.112534_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12874-024-02342-y","article-title":"Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials","volume":"24","author":"Biggs","year":"2024","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib49","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1186\/s13063-024-08625-5","article-title":"How should trial teams make decisions about the proportions and diversity of the ethnic groups in their trial?","volume":"25","author":"Treweek","year":"2024","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112534_bib50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s13063-022-06553-w","article-title":"Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups\u2014practical guidance to support better practice","volume":"23","author":"Dawson","year":"2022","journal-title":"Trials"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626004105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626004105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:57:29Z","timestamp":1793134649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435626004105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":44,"alternative-id":["S0895435626004105"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112534","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capacity-related exclusions in clinical trial protocols are common, with limited assessment and almost no planning for capacity loss","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112534"}}